CHICAGORadiology benefits management companies (RBMs) offer a proven mechanism to control imaging utilization, asserted David C. Levin, MD, of Thomas Jefferson University in Philadelphia during a presentation Monday at the annual meeting of the American Roentgen Ray Society (ARRS). Meanwhile, Levin questioned the real impact of CPOE with decision support.

The Food and Drug Administration (FDA) will hold a public workshop to discuss its recent findings concerning the quality of reprocessing of reusable medical devices.

Younger diabetic patients face high healthcare costs compared to youth without the disease, according to a study published in the Centers for Disease Control and Prevention journal Diabetes Care. These costs were reported to be $9,061 vs. $1,468, respectively.

Excluding women aged 40 to 49 from annual screening mammography exams under the revised U.S. Preventative Service Task Force (USPSTF) mammography guidelines would have a negative effect on survival, according to research presented last week at the American Society of Breast Surgeons annual meeting in Washington, DC.

The Technology Services Industry Association (TSIA) has published its second annual Maintenance Pricing Practices Survey.

The American Academy of Pediatrics (AAP) Council on Clinical Information Technology supports the development and universal implementation of a comprehensive electronic infrastructure to facilitate the pediatric information functions of the medical home, according to its Policy Statement on Health Information Technology and the Medical Home, in the May issue of Pediatrics.

Careful consideration and monitoring will be needed during accountable care organization (ACO) implementation to ensure that ACOs dont widen existing racial and ethnic disparities in healthcare and health outcomes, according to a commentary in the April 27 Journal of the American Medical Association. 

As part of an effort to clarify variable radiotherapy (RT) and chemotherapy treatment regimens, the American Society for Radiation Oncology (ASTRO) has published a series of guidelines for lung cancer treatment, notably concluding that the literature does not support chemotherapy treatment concurrent with palliative RT.